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lung GVHD is currently still on etanercept and stable off steroids.
Five patients are still alive currently. Three patients had SD and
one patient had PD on etanercept. Causes of death included
cGVHD (n2), disease progression (n1) and unknown cause
(n1). Conclusion: In this preliminary evaluation, etanercept was
well tolerated and had activity in patients with cGVHD of the skin,
and potentially in some cases with visceral involvement and failing
corticosteroids. Further dosing and efﬁcacy studies earlier in the
treatment of patients with cGVHD are warranted.
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Donor lymphocyte graft engineering to abrogate graft-vs-host
(GVH) reactivity while improving graft-vs-leukemia (GVL) immu-
nity is of particular interest in allogeneic hematopoietic stem cell
transplantation. We have recently described a protocol to achieve
short-term expansion of donor-derived leukemia-reactive T cells
ex vivo followed by CD137-mediated selective depletion of allo-
reactivity (SAD) to major and ubiquitously expressed minor histo-
compatibility antigens using allogeneic ﬁbroblasts1. For evaluating
GVH and GVL immune responses of modiﬁed donor T cells in
vivo we have now used NOD-scid IL2Rcnull mice to establish a
chimeric transplantation model. GVH reactivity after SAD was
examined by subcutaneously implanting skin substitutes composed
of a collagen-based matrix which contained 6105 human primary
ﬁbroblasts derived from the same pool previously used for SAD.
Upon implantation, substitutes remained viable, induced angio-
genesis and could be dissolved to cell suspensions for further
analyses when removed 3 weeks after implantation. Following
intravenous injection of 1.5107 preactivated untreated allogeneic
human CD3 T cells per mouse, 7–10% of T cells migrated into
the skin substitutes explanted 14 days post adoptive transfer. Such
an enrichment of T cells was not observed when the same number
of CD137-allodepleted T cells were injected. Since xenogenic
GVH reactivity was observed depending on the amount of T cells
used current studies investigate whether residual murine antigen-
presenting cells initiate xeno-reactivity and address its impact on
the migration of T cells into the skin substitutes. To study GVL
immunity we further transplanted different amounts of acute my-
eloid leukemia (AML) cells derived from primary AML patients
(M4 and M5 subtype) into NOD-scid IL2Rcnull mice. Eight
weeks after injection 61% and 17% of isolated spleen and bone
marrow cells, respectively, stained positive for a shared HLA-
class-I epitope and also expressed CD34 as measured by ﬂow
cytometry. Currently, studies are in progress to examine immune
responses to AML by adoptive transfer of human AML-stimulated
allodepleted T cell lines devoid of alloreactivity to AML HLA-
matched ﬁbroblasts. In summary, our NOD-scid/IL2Rcnull trans-
plantation model may be a valuable tool for evaluating GVH and
GVL immunity in vivo following modiﬁcations of donor T lym-
phocytes grafts in vitro.
1 Wehler T and Nonn M, et al. 2006. Blood;epub. Aug. 24.
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We previously showed that alloantigen expression on host
non-hematopoietic cells impaired graft-versus-leukemia (GVL)
effects after allogeneic hematopoietic stem cell transplantation
using chimeric mice expressing alloantigens on hematopoietic
cells alone. C3.Sw (H-2b) mice were lethally irradiated and
injected with T cell depleted bone marrow cells (TCD-BM)
from multiple minor histocompatibilitiy antigens (mHAs) dis-
parate B6 (H-2b) donors. These chimeric mice (BC chimeras),
expressing B6-derived mHAs only on hematopoietic cells, were
lethally irradiated and transplanted with TCD-BM and CD8 T
cells from C3.Sw donors together with B6-derived leukemia
cells, EL-4. In controls we used B63B6 chimeras (BB chime-
ras), expressing B6-derived mHAs on both hematopoietic and
non-hematopoietec cells, as recipients. BB chimeras trans-
planted with TCD-BM  CD8 T cells from C3.Sw exhibited
a signiﬁcant GVL effect but died from leukemia signiﬁcantly
earlier than BC chimeras. To further conﬁrm that alloantigen
expression on non-hematopoietic cells impairs GVL activity,
similar experiments were performed using B63B6-2m deﬁ-
cient chimeras (B- chimeras), lacking functional MHC class I
molecules on non-hematopoietic cells. Leukemia mortality was
signiﬁcantly reduced in B- chimeras compared to BB chimeras,
thus conﬁrming that alloantigen expression on host non-hema-
topoietic cells impairs GVL effects. To elucidate the mechanism
of the reduced GVL effects in BB chimeras, T cells were
isolated from lymph nodes and spleen of chimeras after BMT.
Numbers of donor CD8 T cells in lymph nodes and spleens of
BB recipients decreased much earlier than in BC chimeras in
association with an enhanced apoptosis. CTL activities against
EL-4 signiﬁcantly reduced in BB recipients compared to BC and
B- chimeras. PD-1 expressions on CD8 T cells from BB
chimeras were signiﬁcantly enhanced compared to those from
BC chimeras. These results suggest that alloantigen expression
on host non-hematopoietic cells leads to exhaustion and dys-
function of donor T cells and impairment of GVL effects.
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Our group recently reported an association of single nucleo-
tide polymorphisms (SNPs) within NOD2/CARD15, an impor-
tant intracytoplasmatic receptor of the bacterial ligand mu-
ramyl-dipeptide, with severe GvHD, treatment related
mortality (TRM) and outcome following allogeneic stem cell
transplantation (SCT). As these studies suggested a major role
of dysregulated epithelial inﬂammation, we now tested the role
of SNPs within further receptors involved in cellular sensing of
bacterial ligands. SNPs reported for TLR2, TLR3, TLR4, TLR5
and TLR9 were assessed in recipient (R) and donor (D) DNA
from 259 HLA-identical sibling and 294 matched unrelated
donor transplants. Acute GvHD grade III/IV, 1-yr- and overall
TRM as well as overall survival were correlated with results of
SNP typing, and the inﬂuence of major clinical risk factors as
well as previously assessed presence or absence of NOD2/
CARD15 SNPs was investigated with univariate and multivariate
analyses.
Whereas major SNPs within TLR2, 3, 4 and 9 failed to show
clear associations, the presence of a TLR5-stop codon in the
recipient (n58) showed a trend for higher severe GvHD (22%
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